Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity (2016 - 2025)

Historic Common Equity for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $9.0 million.

  • cbdMD's Common Equity rose 40561.36% to $9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 million, marking a year-over-year increase of 40561.36%. This contributed to the annual value of $7.2 million for FY2025, which is 26803.73% up from last year.
  • As of Q4 2025, cbdMD's Common Equity stood at $9.0 million, which was up 40561.36% from $7.2 million recorded in Q3 2025.
  • Over the past 5 years, cbdMD's Common Equity peaked at $103.1 million during Q3 2021, and registered a low of $665798.0 during Q1 2025.
  • For the 5-year period, cbdMD's Common Equity averaged around $32.4 million, with its median value being $17.4 million (2023).
  • In the last 5 years, cbdMD's Common Equity crashed by 8823.2% in 2024 and then soared by 40561.36% in 2025.
  • Quarter analysis of 5 years shows cbdMD's Common Equity stood at $84.4 million in 2021, then crashed by 68.49% to $26.6 million in 2022, then crashed by 73.54% to $7.0 million in 2023, then crashed by 74.68% to $1.8 million in 2024, then surged by 405.61% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q4 2025, $7.2 million for Q3 2025, and $6.1 million during Q2 2025.